Axon 2959
CAS [329932-55-0]
MF C23H17N3O8MW 463.40
FM19G11 is an HIFα inhibitor with an IC50 value of 80 nM. FM19G11 inhibits HIFα proteins that repress target genes of the two α subunits, in various tumor cell lines as well as in adult and embryonic stem cell models from rodents and humans, respectively.
KEYWORDS: FM19G11 | supplier | HIFα inhibitor | FM 19G11 | FM-19G11 | CAS [329932-55-0] | DNA-RNA | HIF | Inhibitor | Transcription Factors | Embryonic stem cell | Oct4 | Sox2 | Nanog | Tgf-α
V Moreno-Manzano et al. FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status. J Biol Chem. 2010 Jan 8;285(2):1333-42. |
2-Oxo-2-p-tolylethyl 3-(2,4-dinitrobenzamido)benzoate
[329932-55-0]
Axon Medchem的业务之一,是独有的Axon Ligands配体库,在世界范围内,被认为是药物研发的标准。这其中,针对850余种生物靶标(包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等),Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库,Axon Medchem还是欧洲著名的CRO公司,主要针对生物活性分子和药物类似分子展开合成及协议开发工作,在过去的10年中,Axon Medchem已经发现了多种潜在药物分子,并在生物医药界享有一定的声誉。